Results for tag: "Breast Cancer Core Needle Biopsy"

In the Women's Health sector, the Breast Cancer Core Needle Biopsy market encompasses products and procedures utilized for the diagnostic sampling of breast tissue. Core needle biopsy (CNB) is a minimally invasive method for obtaining breast tissue samples for histopathological examination, vital for the accurate diagnosis and staging of breast cancer. The market is driven by technological advancements in biopsy devices, increasing awareness of breast cancer screening, and the rising prevalence of breast cancer worldwide. These devices are designed to extract a small cylinder of tissue with minimal discomfort and scarring. The market reflects an integration of innovations such as image-guided biopsy systems, including ultrasound, stereotactic, and MRI-guided procedures, which improve the precision of tissue sampling. Companies that play a notable role in the Breast Cancer Core Needle Biopsy market include Hologic, Inc., which provides a range of mammography and biopsy solutions; Becton, Dickinson and Company (BD), known for medical technology including biopsy instruments; Devicor Medical Products, Inc., a part of Leica Biosystems, specializing in vacuum-assisted breast biopsy systems; Cook Medical, which develops medical devices used in minimally invasive procedures; and Argon Medical Devices, Inc., which produces products used in various biopsy procedures. These companies are at the forefront of innovation and supply within the field and contribute substantially to advancements in Women's Health diagnostics. Show Less Read more